Frontier IP Matthew White joining the Group as Director of Commercialisation

Neil Crabb, Chief Executive of Frontier IP, said: “It is a real pleasure to welcome Matthew to the Frontier IP team. His superb range of skills and experience provide an excellent match for the work many of our portfolio companies are undertaking.”

Frontier IP (LON:FIPP), which specialises in commercialising university intellectual property, today announced that Matthew White, the Head of Innovation at AB Sugar, one of the world’s largest sugar producers and a wholly-owned subsidiary of AB Foods, is joining the Group as Director of Commercialisation, in a non-board role.

Matthew has 23 years’ experience in technology, product and service innovation, business development and marketing. As AB Sugar’s Head of Innovation, he was responsible for defining strategy and managing a global innovation portfolio. The role involved working extensively with university partners on collaborative research programmes totalling over £20million.

Before joining AB Sugar, Matthew was Director of Consumer Products for international technology consulting and product development business Sagentia Limited, working across a wide range of sectors.

He started his career at Neotronics Scientific, one of the first companies to commercialise electronic odour sensing. He has a Natural Sciences degree majoring in Chemistry from the University of Cambridge.

Matthew White, said: “It is fantastic to be joining everyone at Frontier IP. I am looking forward to using my network and experience to accelerate the commercialisation activities of our exciting portfolio.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Frontier IP Group Plc

    More articles like this

    Frontier IP Group Plc

    Pharma sector embraces industry 4.0

    The medical and pharmaceutical sectors are facing disruption from companies that occupy space traditionally outside of healthcare. These are companies like Apple and Google, plus an array of startups. What does this mean for the healthcare

    Frontier IP Group Plc

    Preston firm raises over £1m to help transform its business

    A Preston manufacturing company has raised £1.34 million towards a new energy efficient factory that will transform its production capacity. Alusid, which is the first spin-out business from the University of Central Lancashire (UCLan), makes sustainable building materials

    Frontier IP Group Plc

    AI’s Impact on Drug Discovery and Development

    Drugs cost too much, for patients, for insurers and even for pharmaceutical companies that design and sell them. A new drug can cost more than a billion dollars to bring to market, and that cost has

    Frontier IP Group Plc

    Alusid Raises £1.3M Funding

    Alusid Ltd uses a patented process to manufacture high quality building materials by recycling industrial waste ceramics and glass, which would otherwise go to landfill. The products are sold under the brand name SilicaStone. It already

    Frontier IP Group Plc

    Frontier IP 10 per cent stake in Amprologix Limited

    Neil Crabb, chief executive of Frontier IP, said: “We are delighted to work with Amprologix to commercialise these potentially life-saving antibiotics, and with a leading industrial partner in the area. It is further sign our business

    Frontier IP Group Plc

    Artificial intelligence in drug discovery and diagnosis

    Machine learning is widely predicted to make drug discovery and patient diagnosis quicker, cheaper and more effective in the future, and signs of this can already be seen. Nearly 70 years ago, artificial intelligence researchers at

    Frontier IP Group Plc

    How could you back Britain’s brightest?

    In higher education, the UK is a superpower. Four of the 10 top-rated universities in the world are British. Interestingly, they’re not just centres of academic excellence. Defibrillators, LCD screens, Maglev trains, pacemakers and fibre optics are

    Frontier IP Group Plc

    CEO Q&A with Neil Crabb at Frontier IP Group Plc (LON:FIPP)

    Frontier IP Group’s Neil Crabb discusses their partnership with the Department for International Trade, progress in Portugal, why they chose Portugal and future updates for their portfolio companies in this exclusive interview with DirectorsTalk